Live tape
Top 8, mentions 7d13,386TSLA3,041 mentions▲ +0.05SPCX2,592 mentions▲ +0.08GOOGL1,788 mentions▲ +0.03META1,437 mentions▲ +0.05CRWV1,266 mentions▲ +0.04NVDA1,179 mentions▲ +0.07QQQ1,135 mentions▲ +0.05NFLX948 mentions▲ +0.03

Equity · Healthcare

INSP

NYSE

Inspire Medical Systems (INSP)

$51 −0.93% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for INSP to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $1.5B
P/E (TTM) 11.3
52-week range $40 – $144
Avg volume 176.3K

as of Jul 17, 2026

Inspire Medical Systems (INSP) insider trades

SEC Form 4 · last 90 days · newest reported trade 7 Aug 2026

In the 90 days to 22 Oct 2026, Inspire Medical Systems insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 14 Oct 2025, show no open-market purchase.

Open-market buys 0
Open-market sells 1
Net sold $57K
Non-trade filings 6
Date Insider Type Shares Value
07 Aug 2026 Kelly Jason P See Remarks Sell 963 $57K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
14 Oct 2026 Ellis Gary Lee Director Award 431 $29K
14 Oct 2026 Melenikiotou Georgia Director Award 255 $17K
14 Oct 2026 CARREL MICHAEL H Director Award 203 $14K
14 Oct 2026 Broader Shelley G Director Award 284 $19K
31 Aug 2026 Kelly Jason P See Remarks Award 6,350
31 Jul 2026 Mann Melissa Chief People Officer Tax withheld 326 $16K

Inspire Medical Systems (INSP) reported financials

SEC EDGAR XBRL SEC EDGAR

Inspire Medical Systems reported revenue of $912.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was $145.4M.

Figure Reported Period
Revenue $912.0M 31 Dec 2025 fiscal year
Net income $145.4M 31 Dec 2025 fiscal year
Diluted EPS $4.89 31 Dec 2025 fiscal year
Total assets $926.0M 30 Jun 2026 at period end
Total equity $825.6M 30 Jun 2026 at period end

Inspire Medical Systems (INSP) earnings

SEC EDGAR

Inspire Medical Systems last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.01; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.01 —
31 Mar 2026 Q1 2026 −$0.39 —
31 Dec 2025 FY 2025 $4.89 —
30 Sep 2025 Q3 2025 $0.34 —
30 Jun 2025 Q2 2025 −$0.12 —
31 Mar 2025 Q1 2025 $0.10 —
31 Dec 2024 FY 2024 $1.75 —
30 Sep 2024 Q3 2024 $0.60 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Inspire Medical Systems (INSP) institutional holders (13F)

SEC Form 13F SEC EDGAR

6 of the 45 institutional funds we track reported a Inspire Medical Systems position for the quarter ended 30 Jun 2026 — a combined $199.9M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Added +501.6% shares 1,856,800 $80.9M
D. E. Shaw & Co. Held (±25%) +23.7% shares 1,470,462 $65.6M
Citadel Advisors Added +28.5% shares 506,334 $22.6M
Renaissance Technologies Held (±25%) −9.4% shares 426,000 $19.0M
Tudor Investment Corp Held (±25%) +1.1% shares 169,095 $7.5M
Millennium Management Trimmed −75.6% shares 94,149 $4.2M
Balyasny Asset Management Exited
Bridgewater Associates Exited
Man Group Exited
Two Sigma Investments Exited

Inspire Medical Systems (INSP) fails-to-deliver

SEC CNS data SEC

On 22 Sep 2026, 4,648 shares of Inspire Medical Systems failed to deliver (about $352K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
22 Sep 2026 4,648 $352K 0.016%
21 Sep 2026 804 $62K 0.003%
16 Sep 2026 143 $11K <0.001%
15 Sep 2026 17 $1K <0.001%

Congressional trades in Inspire Medical Systems (INSP)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Inspire Medical Systems is a sale by Daniel S. Goldman (house, NY), dated 10 Apr 2023.

Date Member Type Amount
10 Apr 2023 filed 19 May 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K

Inspire Medical Systems (INSP): frequently asked questions

From live data

Have Inspire Medical Systems insiders bought or sold shares recently?

In the 90 days to 22 Oct 2026, Inspire Medical Systems insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 14 Oct 2025, show no open-market purchase. A further 6 filings were grants, awards, gifts or exercises rather than open-market trades.

How many institutions hold Inspire Medical Systems?

6 of the 45 institutional funds we track reported a Inspire Medical Systems position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Inspire Medical Systems had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Inspire Medical Systems is dated 22 Sep 2026, when 4,648 shares failed to deliver.

When did Inspire Medical Systems last report earnings?

Inspire Medical Systems last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $0.01; no next date is announced in SEC filings yet.

What exchange is Inspire Medical Systems listed on?

Inspire Medical Systems trades on NYSE under the ticker INSP.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings